Showing results (51-60 of 3,316) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|December 27, 2011
Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorderLev Gertsik, Russell E Poland, Catherine Bresee, et al.Journal of Clinical Psychopharmacology|December 27, 2011
Variation in antipsychotic treatment choice across US nursing homesKrista F Huybrechts, Kenneth J Rothman, M Alan Brookhart, et al.Journal of Clinical Psychopharmacology|December 27, 2011
Asenapine versus olanzapine in people with persistent negative symptoms of schizophreniaRobert W Buchanan, John Panagides, Jun Zhao, et al.Journal of Clinical Psychopharmacology|December 27, 2011
Tetrabenazine augmentation in treatment-resistant schizophrenia: a 12-week, double-blind, placebo-controlled trialGary Remington, Shitij Kapur, George Foussias, et al.Journal of Clinical Psychopharmacology|December 27, 2011
Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insuranceJennifer M Polinski, M Alan Brookhart, Robert J Glynn, et al.Journal of Clinical Psychopharmacology|April 22, 2011
Treating generalized anxiety disorder with second generation antipsychotics: a systematic review and meta-analysisCarlos D LaLonde, Ryan J Van LieshoutJournal of Clinical Psychopharmacology|April 22, 2011
Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia TrialPeter Malik, Georg Kemmler, Martina Hummer, et al.Journal of Clinical Psychopharmacology|April 22, 2011
A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophreniaBruce J Kinon, Lu Zhang, Brian A Millen, et al.Journal of Clinical Psychopharmacology|April 22, 2011
Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatmentPernilla J Schweitzer, Uzma Zafar, Martina Pavlicova, et al.Journal of Clinical Psychopharmacology|April 22, 2011
Short-term effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy volunteersSilke Conen, Eef L Theunissen, Annemiek Vermeeren, et al.Pageof 332